Home > Press > A novel method for identifying the body’s ‘noisiest’ networks
Image via Shutterstock |
Abstract:
A team of scientists led by Yale University systems biologist and biomedical engineer Andre Levchenko has developed a novel method for mapping the biochemical variability, or "noise," in how human cells respond to chemical signals. The research, published Nov. 17 in Proceedings of the National Academy of Science, could be used to tailor drug delivery to a patient's individual cell responses and may have further implications for advances in semiconductor chip design.
Levchenko's method is founded on the recognition that every cell reacts uniquely to the body's chemical signals, even if the cells are all from the same patient and even the same tissue — some cells may react strongly, while other cells may not react at all. A wide diversity of responses is considered a noisy response.
The new method maps noise across multiple branches of complicated biochemical networks. "Knowing how variable the activity is allows us to better target the spectra of activities in those networks," said Levchenko, the John C. Malone Professor of Biomedical Engineering and inaugural director of the Yale Systems Biology Institute.
"For example, if a specific cell network's spectra of response is less noisy, then a comparatively small drug dosage could target the entire spectra. Our mapping technique enables researchers and clinicians to identify those less noisy networks, which could be unique for each patient," he said.
For this research, Levchenko's team — including Alex Rhee and Raymond Cheong of Johns Hopkins University — looked at a signaling system stimulated by cytokine tumor necrosis factor (TNF), which is commonly produced by cells responding to infections. When the body's sentinel cells detect foreign materials, they broadcast the TNF molecule to activate the first line of immune response.
Using a combination of experimental observations and mathematical algorithms, the team measured the effect of TNF input for a small number of target molecules, then inferred how the signal triggers by TNF propagated through the network. Because the TNF signal originated from the same point, the team could efficiently reconstruct how different branches of the cell communication networks reacted to the signal without measuring the dozens of molecules affected.
"Previous experiments in this field, including our own, would focus on these network responses by looking at the average cell behavior over perhaps millions of cells at a time," said Levchenko. "The new method is unique in that it requires relatively few targets — we observed just three target transcription factors — to reconstruct not only how responsive but also how noisy various branches of the signaling network are. Using this effective methodology, we can now embark on extensive mapping of the sources of noise across signaling networks."
In turn, identifying which networks were noisier enabled Levchenko's team to experimentally confirm that noise tends to increase as the communication chain gets longer, something that could be applicable to research of not only biological networks but even electrical networks.
"Despite the noise in cellular networks," he said, "biology still allows cells and organisms to perform well. Similarly, as today's electronic components become smaller, chip designers more often need to study and circumvent signaling noise. For this reason, the challenges of building effective computational devices and designing effective medical therapeutics are more similar than meets the eye."
Reflecting this interdisciplinary nature, the research was supported by both the National Institutes of Health and the Semiconductor Research Corporation.
####
For more information, please click here
Contacts:
Jim Shelton
203-361-8332
Copyright © Yale University
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Chip Technology
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||